Data, Peptides, and AI: 2026 Quarter 2 Pharmacy Update with Dr. Nicolette Mathey, PharmD, Dotti CRM
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Data, Peptides, and AI: 2026 Quarter 2 Pharmacy Update with Dr. Nicolette Mathey, PharmD, Dotti CRM
-
ナレーター：
-
著者：
Send us Fan Mail
Send us Fan Mail
Schedule an Rx Assessment
What's really going on with peptides, AI, and the future of independent pharmacy? Turns out, quite a lot.
Dr. Nicolette Mathey, PharmD, Founder and CEO of Atrium24 and Dotti CRM, for her quarterly update on the independent pharmacy landscape.
We talk about:
- Headwinds and tailwinds for Q2 of independent pharmacy
- Upcoming PCAC meeting and what it means for peptide compounding
- The dangerous peptide gray market
- How AI is eliminating inefficiencies and transforming pharmacy sales
And more!
Stay connected with Nicolette, Atrium24, and Dotti:
Nicolette’s LinkedIn
Atrium24 Website
Atrium24 Facebook
Atrium24 LinkedIn
Stay connected with us:
Facebook
Twitter
LinkedIn
Scotty Sykes – CPA, CFP LinkedIn
Scotty Sykes – CPA, CFP Twitter
Bonnie Bond – CPA LinkedIn
Bonnie Bond – CPA Twitter
More resources on this topic:
Podcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24
Podcast – A Pharmacists Run for Congress with Dr. Didi Okpareke, PharmD, RPh
Podcast – KPIs for the Rapid Growth Pharmacy with Jim Hrncir, R. Ph, Owner of Las Colinas Compounding Pharmacy